skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi Team, sold my shares of RHT this morning. Transferring remaining capital from sale to US RRSP for another healthcare name. Someone on T.V last night was screaming Medtronic for a buy ,from my own readings and research I see Stryker as a good choice. Between the 2 which has a better growth profile. Which would you choose. I own ABBV and BDX for a total healthcare exposure of 17%. I Thank-you in advance! Like usual,......Great work team! Sam
Read Answer Asked by sam on October 17, 2018
Q: Hello,
I would like some names to consider (2 or 3) for the healthcare sector.

I already own GUD in Canada (TFSA). This is for my RRSP so I am looking for a more conservative name.

I know you don't cover the US but would like names from the US or even international for geographic diversification. Also, for personal reasons, I do not want any drug companies (pharma or biotech).

Thanks as always for your help.
Dan
Read Answer Asked by Daniel on August 27, 2018
Q: Good evening 5i gang. Stryker has dropped with the talk about Boston Scientific purchase. Could this be a good time to purchase more. ? I have half a position. Should we expect more volitility?
Also..I just want to say thankyou. I joined in around March or April 2014. I am up 50%. That was one of the best decisions of my life.
Thank you
Read Answer Asked by El-ann on June 13, 2018
Q: 10,000 Americans a day will reach the age of 65 and this will continue for the next 19 years. That's 3,500,000 a year times 19 years. More walkers, hips, knees, wheelchairs, nursing homes, retirement homes, pain pills, drugs. More of what Savaria ( SIS ) produces. Great for Savaria !

What other Canadian & U.S. Companies will benefit from this great explosion of aging of America . Is Canada in a similar situation. Baby Boombers, Bob
Read Answer Asked by bob on March 30, 2017
Q: The above group of companies, so called bond proxies medical supply and consumer staples do not seem to be participating in the Trump boost post election. Many have sold off sharply. Do you view this as a buying opportunity?
Read Answer Asked by Andrew on November 29, 2016
Q: Hello Folks:
In reading your answers to previous questions on GILD you recommend the company for it's strong cash position and low valuation, but recommend having the patience of a 2 year outlook. I have owned GILD for several years and not done very well as of late. Being I am 70 yrs. old should I hang in with GILD or move into another health related company? I have a full position with Johnson & Johnson, but am unaware of other very good health care options. I am not a frequent trader, tending to hold mostly American blue-chip companies,and welcome your advice...I greatly appreciate your good service!
brian
Read Answer Asked by Brian on November 28, 2016
Q: Hello,

We need to add US Healthcare to our portfolio. We already own GSK and MRK. We are looking at Zimmer holdings ( ZMH ) or Stryker corp ( SYK ). With the aging population, knees and hips replacment should be on the rise.
Could you give me your opinion on these two and possibly an alternative if you don't know them.

Thanks
Read Answer Asked by Josette on December 01, 2013
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!